BofA Securities Starts Lyell Immunopharma (LYEL) at Buy
Tweet
Share
E-mailGet Alerts LYEL Hot Sheet
Price: $13.55 -2.87%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
BofA Securities initiates coverage on Lyell Immunopharma (NASDAQ: LYEL) with a Buy rating and a price target of $25.00.
For an analyst ratings summary and ratings history on Lyell Immunopharma click here. For more ratings news on Lyell Immunopharma click here.
Shares of Lyell Immunopharma closed at $15.88 yesterday.
You May Also Be Interested In
- Lyell Immunopharma (LYEL) Reiterated at Market Outperform by Citizens
- Wells Fargo Starts Huntington Bancshares (HBAN) at Overweight
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
